Perspective Therapeutics (CATX) Capital Expenditures (2010 - 2026)
Perspective Therapeutics (CATX) posted Capital Expenditures of $12.7 million for Q4 2025, up 32374.36% sequentially from $39000.0 in Q3 2025, and down 13.34% YoY from $14.6 million in Q4 2024.
Perspective Therapeutics (CATX) Capital Expenditures (2010 - 2026) Analysis & Trends
Perspective Therapeutics has reported Capital Expenditures for 16 years, with the latest figure at $12.7 million in Q4 2025.
- Quarterly Capital Expenditures fell 13.34% year-over-year to $12.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $8.1 million (down 86.3% YoY) and the FY2025 annual result came in at $12.7 million, down 76.57% from the prior year.
- Capital Expenditures grew to $12.7 million in Q4 2025 per CATX's latest filing, from $39000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $29.7 million in Q3 2024 and troughed at -$4.6 million in Q2 2025.
- A 5-year average of $3.8 million and a median of $176000.0 in 2022 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2021 and 2024: Capital Expenditures tumbled 243.33% in 2021, then soared 16320.22% in 2024.
- Over 5 years, Capital Expenditures stood at -$86000.0 in 2021, then soared by 275.58% to $151000.0 in 2022, then plunged by 41.06% to $89000.0 in 2023, then jumped by 16320.22% to $14.6 million in 2024, then dropped by 13.34% to $12.7 million in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $12.7 million, $39000.0, and -$4.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.74 Bn | 197.14 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 127.22 Bn | 123.75 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.44 Bn | 110.22 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 74.78 Bn | 74.24 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.81 Bn | 47.56 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.98 Bn | 33.03 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.79 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.24 Bn | 22.76 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Perspective Therapeutics | 407.80 Mn | 407.80 Mn | - | 14.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.20 Mn |
| Jun 30, 2026 | 14.20 Mn |
| Mar 31, 2026 | 6.86 Mn |
| Mar 31, 2026 | 6.86 Mn |
| Dec 31, 2025 | 12.67 Mn |
| Dec 31, 2025 | 12.67 Mn |
| Sep 30, 2025 | 39,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Jun 30, 2025 | -4.61 Mn |
| Jun 30, 2025 | -4.61 Mn |
| Mar 31, 2025 | 4.66 Mn |
| Mar 31, 2025 | 4.66 Mn |
| Dec 31, 2024 | 14.61 Mn |
| Dec 31, 2024 | 14.61 Mn |
| Sep 30, 2024 | 29.71 Mn |
| Sep 30, 2024 | 29.71 Mn |
| Jun 30, 2024 | 10.09 Mn |
| Jun 30, 2024 | 10.09 Mn |
| Dec 31, 2023 | 89,000.00 |
| Dec 31, 2023 | 89,000.00 |